Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
CEO, Director
-
Stock Symbol
-
ROIV on Nasdaq
Matthew Gline - trading volume in the past year for Roivant Sciences Ltd.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Shares |
17.4M |
$207M |
$11.92 |
Oct 20, 2024 |
Direct |
|
|
| Capped Value Appreciation Rights |
0 |
$0 |
$6.40 |
Mar 30, 2024 |
Direct |
Common Shares |
|
| Stock Option (Right to Buy) |
15M |
|
|
Sep 23, 2024 |
Direct |
Common Stock |
|
Transactions reported by Matthew Gline for Roivant Sciences Ltd.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.